Sonova Holding AG (SONVY)
64.22
-1.26
(-1.92%)
USD |
OTCM |
May 17, 16:16
Sonova Shareholders Equity (Quarterly): 2.738B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.738B |
| September 30, 2023 | 2.307B |
| September 30, 2023 | 2.307B |
| March 31, 2023 | 2.422B |
| September 30, 2022 | 2.035B |
| September 30, 2022 | 2.035B |
| March 31, 2022 | 2.611B |
| September 30, 2021 | 2.726B |
| September 30, 2021 | 2.726B |
| March 31, 2021 | 2.917B |
| September 30, 2020 | 2.469B |
| September 30, 2020 | 2.469B |
| March 31, 2020 | 2.095B |
| September 30, 2019 | 2.254B |
| September 30, 2019 | 2.254B |
| March 31, 2019 | 2.364B |
| September 30, 2018 | 2.306B |
| September 30, 2018 | 2.306B |
| March 31, 2018 | 2.571B |
| September 30, 2017 | 2.264B |
| September 30, 2017 | 2.264B |
| Date | Value |
|---|---|
| March 31, 2017 | 2.107B |
| September 30, 2016 | 1.937B |
| September 30, 2016 | 1.937B |
| March 31, 2016 | 1.950B |
| September 30, 2015 | 1.795B |
| September 30, 2015 | 1.795B |
| March 31, 2015 | 1.906B |
| September 30, 2014 | 1.936B |
| September 30, 2014 | 1.936B |
| March 31, 2014 | 1.967B |
| September 30, 2013 | 1.771B |
| September 30, 2013 | 1.771B |
| March 31, 2013 | 1.698B |
| September 30, 2012 | 1.701B |
| September 30, 2012 | 1.701B |
| March 31, 2012 | 1.633B |
| September 30, 2011 | 1.428B |
| March 31, 2011 | 1.458B |
| September 30, 2010 | 1.409B |
| March 31, 2010 | 1.193B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.035B
Minimum
Sep 2022
2.917B
Maximum
Mar 2021
2.424B
Average
2.422B
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| AC Immune SA | 160.35M |
| CRISPR Therapeutics AG | 2.084B |
| Addex Therapeutics Ltd | 1.364M |
| NLS Pharmaceutics Ltd | -4.287M |
| Molecular Partners AG | 210.05M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.419B |
| Total Liabilities (Quarterly) | 3.658B |
| Debt to Equity Ratio | 0.6135 |
| Current Ratio | 1.452 |
| Net Debt Paydown Yield | -3.24% |